The company expired its plan on April 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.03 CNY | +0.20% | +0.27% | -0.73% |
29/04 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.73% | 2.48B | |
+38.33% | 705B | |
+32.82% | 583B | |
-3.67% | 364B | |
+20.14% | 332B | |
+5.13% | 291B | |
+17.29% | 238B | |
-3.68% | 210B | |
+10.47% | 209B | |
+8.54% | 169B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 6, 2022, has expired.